In patients with acute coronary syndrome (ACS), coronary artery bypass graft (CABG) surgery performed 2-3 days after ticagrelor cessation showed noninferiority with respect to perioperative bleeding ...

Perioperative morbidity and mortality are slightly reduced with coronary artery bypass grafting (CABG) performed off-pump (OPCAB) by experienced surgeons, according to a study presented at the annual ...

MADRID, Spain—Adding ticagrelor on top of aspirin alone for 1 year does not lower the incidence of death, MI, stroke, or repeat revascularization in ACS patients who undergo CABG surgery, according to ...

ANAHEIM, CA — A new trial shows the combination of aspirin plus ticagrelor (Brilinta, AstraZeneca) resulted in significant improvement in saphenous vein graft (SVG) patency at 12 months compared with ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin alone, ...

Reliance on CTA-derived FFR produced more perfectly patent grafts than QCA ...